Infection, Super Infection and Antimicrobial Management in ICU

Assessing the risk of difficult-to-treat bacterial superinfections, such as multidrug-resistant (MDR) Gram-negative bacilli, according to comorbidities, lung abnormalities or systemic diseases, the severity of pneumonia and the risks of drug-related effects are crucial points for the clinical manage...

Full description

Saved in:
Bibliographic Details
Other Authors: Brazzi, Luca (Editor), Montrucchio, Giorgia (Editor)
Format: Electronic Book Chapter
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_113867
005 20230911
003 oapen
006 m o d
007 cr|mn|---annan
008 20230911s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-8381-5 
020 |a 9783036583808 
020 |a 9783036583815 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-8381-5  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
100 1 |a Brazzi, Luca  |4 edt 
700 1 |a Montrucchio, Giorgia  |4 edt 
700 1 |a Brazzi, Luca  |4 oth 
700 1 |a Montrucchio, Giorgia  |4 oth 
245 1 0 |a Infection, Super Infection and Antimicrobial Management in ICU 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (144 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Assessing the risk of difficult-to-treat bacterial superinfections, such as multidrug-resistant (MDR) Gram-negative bacilli, according to comorbidities, lung abnormalities or systemic diseases, the severity of pneumonia and the risks of drug-related effects are crucial points for the clinical management. Despite the wide-and not always appropriate-use of broad-spectrum antimicrobials, specific data about bacterial and fungal co-infection in COVID-19 patients are lacking, and confirmed evidence is urgently required to build prospective evidence and to support the development of antimicrobial policy and appropriate stewardship interventions. The present Special Issue aims to focus on the following key points: Importance of superinfections in COVID-19 patients who are typically characterized by immunosuppression related to viral infection, need for prolonged hospitalization, treatment with immunomodulatory therapies (steroids, monoclonal antibodies, etc.); Their impact on the outcome of a cohort of patients who are relatively young, with few comorbidities, but requiring prolonged invasive support; Incidence, characteristics and impact of bacterial infections caused by multidrug-resistant, Gram-negative pathogens in the context of COVID-19 disease; Incidence, characteristics and impact of fungal infections, such as the most known invasive aspergillosis but also candidemia and/or other fungal infections (e.g., mucormycosis); Antimicrobial surveillance, control and management measures as implemented on a local, national and international basis. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
653 |a Superinfections 
653 |a COVID-19 
653 |a SARS-CoV-2 
653 |a multidrug-resistant pathogens 
653 |a antimicrobial stewardship 
653 |a antimicrobial resistance 
653 |a fungal infections 
653 |a bacterial infections 
653 |a intensive care medicine 
653 |a critical care medicine 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/7708  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/113867  |7 0  |z DOAB: description of the publication